Harvard Mental Health Letter

References for "Cytochrome P450 enzymes and psychiatric drugs"

Bondy B, et al. "Pharmacogenetics of Antipsychotics: Useful for the Clinician?" Current Opinion in Psychiatry (March 2007): Vol. 20, No. 2, pp. 126–30. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17278909

De Leon J, et al. "Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19," Psychosomatics (Jan.–Feb. 2006): Vol. 47, No. 1, pp. 75–85. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16384813

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. "Recommendations from the EGAPP Working Group: Testing for Cytochrome P450 Polymorphisms in Adults with Nonpsychotic Depression Treated with Selective Serotonin Reuptake Inhibitors," Genetics in Medicine (Dec. 2007): Vol. 9, No. 12, pp. 819–25. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18091431

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »